Short pages

Showing below up to 50 results in range #51 to #100.

51. (hist) Fruit bats as natural reservoir of highly pathogenic henipaviruses: balance between antiviral defense and viral tolerance [1,113 bytes]
52. (hist) Laboratory Diagnosis of Hendra and Nipah: Two Emerging Zoonotic Diseases with One Health Significance [1,116 bytes]
53. (hist) Stakeholder Perspective of Handling the Deceased during the Nipah Virus Outbreak in Kerala, South India, 2018 [1,119 bytes]
54. (hist) Molecular characterization of Nipah virus from Pteropus hypomelanus in Southern Thailand [1,119 bytes]
55. (hist) Scoping future outbreaks: a scoping review on the outbreak prediction of the WHO Blueprint list of priority diseases [1,127 bytes]
56. (hist) Nipah Virus Detection in Pteropus hypomelanus Bats, Central Java, Indonesia [1,131 bytes]
57. (hist) Severe zoonotic viruses carried by different species of bats and their regional distribution [1,134 bytes]
58. (hist) Evolution of Nipah Virus Infection: Past, Present, and Future Considerations [1,140 bytes]
59. (hist) A Novel Model of Lethal Hendra Virus Infection in African Green Monkeys and the Effectiveness of Ribavirin Treatment [1,141 bytes]
60. (hist) The Nature of Exposure Drives Transmission of Nipah Viruses from Malaysia and Bangladesh in Ferrets [1,144 bytes]
61. (hist) Henipaviruses: an expanding global public health concern? [1,145 bytes]
62. (hist) Nipah Virus Disease: Recent Perspective and One Health Approach [1,149 bytes]
63. (hist) Sero-prevalence of Nipah antibodies among close contacts of the index case during 2019 Ernakulam outbreak [1,153 bytes]
64. (hist) Encephalitis-predominant Nipah virus outbreaks in Kerala, India during 2024 [1,161 bytes]
65. (hist) Structural and functional analysis of the Nipah virus polymerase complex [1,162 bytes]
66. (hist) A comparative genomic approach to decipher the mutations associated with Nipah viral human isolates from southeast Asia [1,164 bytes]
67. (hist) Recently Emerged Novel Henipa-like Viruses: Shining a Spotlight on the Shrew [1,164 bytes]
68. (hist) Highly sensitive and quantitative HiBiT-tagged Nipah virus-like particles: A platform for rapid antibody neutralization studies [1,167 bytes]
69. (hist) A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for a soluble glycoprotein vaccine to prevent disease caused by Nipah or Hendra viruses [1,168 bytes]
70. (hist) Smart policy changes can quell deadly Nipah virus [1,168 bytes]
71. (hist) Zoonotic Paramyxoviruses: Evolution, Ecology, and Public Health Strategies in a Changing World [1,172 bytes]
72. (hist) Research on emerging infectious diseases: pros and cons of centralised government controls [1,173 bytes]
73. (hist) Letter to editor: Serosurvey for Nipah virus in bat population of southern part of India [1,186 bytes]
74. (hist) An Immunoinformatic-Based In Silico Identification on the Creation of a Multiepitope-Based Vaccination Against the Nipah Virus [1,188 bytes]
75. (hist) Lessons from the pandemic: Responding to emerging zoonotic viral diseases—a Keystone Symposia report [1,189 bytes]
76. (hist) Exact calculation of end-of-outbreak probabilities using contact tracing data [1,191 bytes]
77. (hist) Hendra and Nipah viruses: different and dangerous [1,195 bytes]
78. (hist) Recurrent Nipah outbreaks in Kerala: implications for health policy and preparedness [1,195 bytes]
79. (hist) Nipah virus: pathogenesis, genome, diagnosis, and treatment [1,197 bytes]
80. (hist) Advancements in Nipah virus treatment: Analysis of current progress in vaccines, antivirals, and therapeutics [1,198 bytes]
81. (hist) Navigating Nipah virus: Insights, challenges, and recommendations [1,199 bytes]
82. (hist) Immunological correlates of protection afforded by PHV02 live, attenuated recombinant vesicular stomatitis virus vector vaccine against Nipah virus disease [1,202 bytes]
83. (hist) Super-spreaders of novel coronaviruses that cause SARS, MERS and COVID-19: a systematic review [1,203 bytes]
84. (hist) Discovery of a Novel Parahenipavirus, Parahenipavirus GH, in Shrews in South Korea, 2022 [1,206 bytes]
85. (hist) Pathogenicity and virulence of henipaviruses [1,207 bytes]
86. (hist) Aerosol exposure to intermediate size Nipah virus particles induces neurological disease in African green monkeys [1,207 bytes]
87. (hist) A review of the nipah virus [1,211 bytes]
88. (hist) Current progress towards prevention of Nipah and Hendra disease in humans: A scoping review of vaccine and monoclonal antibody candidates being evaluated in clinical trials [1,211 bytes]
89. (hist) Beyond the Headlines: Why Henipaviruses Warrant Our Attention [1,212 bytes]
90. (hist) Nipah amidst Covid-19 Pandemic – another Re-Emerging Infectious Disease of Pandemic Potential – a Narrative Review [1,217 bytes]
91. (hist) Controlling Nipah virus encephalitis in Bangladesh: Policy options [1,218 bytes]
92. (hist) Host–Pathogen Interactions Influencing Zoonotic Spillover Potential and Transmission in Humans [1,218 bytes]
93. (hist) Nipah Virus: An Overview of the Current Status of Diagnostics and Their Role in Preparedness in Endemic Countries [1,226 bytes]
94. (hist) A Comparative Analysis of Statistical Methods to Estimate the Reproduction Number in Emerging Epidemics, With Implications for the Current Coronavirus Disease 2019 (COVID-19) Pandemic [1,230 bytes]
95. (hist) Clinical Medicine 2022 Vol 22, No 4: 348–52 - Review of Nipah virus encephalitis [1,230 bytes]
96. (hist) Metagenomic Snapshots of Viral Components in Guinean Bats [1,230 bytes]
97. (hist) Bats and viruses: a death-defying friendship [1,232 bytes]
98. (hist) Evaluation of a Single-Dose Nucleoside-Modified Messenger RNA Vaccine Encoding Hendra Virus-Soluble Glycoprotein Against Lethal Nipah virus Challenge in Syrian Hamsters [1,234 bytes]
99. (hist) Science. 2022 March 25; 375(6587): 1373–1378. [1,238 bytes]
100. (hist) Outbreak prone communicable diseases of public health importance in the northern districts of West Bengal – Current status & the way forward [1,240 bytes]